NCT00351468 - EXTEND (Eltrombopag Extended Dosing Study) | Biotech Hunter

Enrollment

302

Participants

Timeline

Start Date

June 30, 2006

Primary Completion Date

July 31, 2015

Study Completion Date

July 31, 2015

Conditions

Purpura, Thrombocytopaenic, Idiopathic

Interventions

DRUG

eltrombopag olamine (SB-497115-GR)

Eltrombopag with starting dose of 50mg daily, max dose of 75mg daily and min dose of 25mg daily or less frequently. Modifications were given to maintain platelet count in range of 50 to 200 Gi/L.

Trial Locations (110)

100

Novartis Investigative Site, Taipei

1000

Novartis Investigative Site, Ljubljana

1001

Novartis Investigative Site, Grafton

1008

Novartis investigative Site, Montfleury

Novartis Investigative Site, Tunis

2024

Novartis Investigative Site, Auckland

2217

Novartis Investigative Site, Kogarah

2606

Novartis investigative Site, Garran

3029

Novartis investigative Site, Sfax

4000

Novartis Investigative Site, Sousse

5000

Novartis Investigative Site, Odense

8011

Novartis Investigative Site, Christchurch

10021

Novartis Investigative Site, New York

10330

Novartis Investigative Site, Bangkok

10676

Novartis Investigative Site, Athens

11525

Novartis Investigative Site, Athens

13353

Novartis Investigative Site, Berlin

14033

Novartis Investigative Site, Caen

15706

Novartis Investigative Site, Santiago de Compostela

20132

Novartis investigative Site, Milan

22205

Novartis Investigative Site, Arlington

28006

Novartis Investigative Site, Madrid

28007

Novartis Investigative Site, Madrid

30159

Novartis Investigative Site, Hanover

30341

Novartis Investigative Site, Atlanta

30625

Novartis Investigative Site, Hanover

31008

Novartis Investigative Site, Pamplona

31405

Novartis Investigative Site, Savannah

33136

Novartis Investigative Site, Miami

33604

Novartis Investigative Site, Pessac

35128

Novartis Investigative Site, Padua

35392

Novartis Investigative Site, Giessen

35805

Novartis Investigative Site, Huntsville

36608

Novartis Investigative Site, Mobile

40002

Novartis Investigative Site, Khon Kaen

40138

Novartis Investigative Site, Bologna

44106

Novartis Investigative Site, Cleveland

48202

Novartis Investigative Site, Detroit

49102

Novartis Investigative Site, Dnipropetrovsk

54600

Novartis Investigative Site, Lahore

55337

Novartis Investigative Site, Brunsville

57010

Novartis Investigative Site, Thessaloniki

61614

Novartis Investigative Site, Peoria

66113

Novartis Investigative Site, Saarbrücken

70115

Novartis Investigative Site, New Orleans

70210

Novartis Investigative Site, Kuopio

72401

Novartis Investigative Site, Jonesboro

75300

Novartis Investigative Site, Karachi

79044

Novartis Investigative Site, Lviv

79410

Novartis Investigative Site, Lubbock

80639

Novartis Investigative Site, Munich

87109

Novartis Investigative Site, Albuquerque

90033

Novartis Investigative Site, Los Angeles

91010

Novartis Investigative Site, Duarte

94010

Novartis Investigative Site, Créteil

94143

Novartis Investigative Site, San Francisco

97227

Novartis Investigative Site, Portland

98109

Novartis Investigative Site, Seattle

98405

Novartis Investigative Site, Tacoma

98684

Novartis Investigative Site, Vancouver

125167

Novartis Investigative Site, Moscow

193024

Novartis investigative Site, Saint Petersburg

200025

Novartis Investigative Site, Shanghai

215006

Novartis Investigative Site, Jiang Su Province

300020

Novartis Investigative Site, Tianjin

630087

Novartis Investigative Site, Novosibirsk

02114

Novartis Investigative Site, Boston

A-1090

Novartis Investigative Site, Vienna

L8S 4K1

Novartis Investigative Site, Hamilton

H2L 4M1

Novartis Investigative Site, Montreal

H3T 1E2

Novartis Investigative Site, Montreal

625 00

Novartis Investigative Site, Brno

775 20

Novartis Investigative Site, Olomouc

128 20

Novartis Investigative Site, Prague

Unknown

Novartis Investigative Site, Shatin, New Territories

Novartis Investigative Site, Ho Chi Minh City

00041

Novartis Investigative Site, Albano Laziale (Roma)

3816 CP

Novartis Investigative Site, Amersfoort

1105 AZ

Novartis Investigative Site, Amsterdam

6525 GA

Novartis Investigative Site, Nijmegen

3015 GE

Novartis Investigative Site, Rotterdam

2545 CH

Novartis Investigative Site, The Hague

0622

Novartis Investigative Site, Takapuna, Auckland

Lima 41

Novartis Investigative Site, Lima

Lima 27

Novartis Investigative Site, Lima

15-276

Novartis Investigative Site, Bialystok

93-510

Novartis Investigative Site, Lodz

20-081

Novartis Investigative Site, Lublin

76-200

Novartis Investigative Site, Słupsk

87-100

Novartis Investigative Site, Torun

50-367

Novartis Investigative Site, Wroclaw

022328

Novartis Investigative Site, Bucharest

050098

Novartis Investigative Site, Bucharest

105 229

Novartis Investigative Site, Moscow

041 90

Novartis Investigative Site, Košice

080 01

Novartis Investigative Site, Prešov

136-705

Novartis Investigative Site, Seoul

08916

Novartis Investigative Site, Badalona/Barcelona

08025

Novartis Investigative Site, Barcelona

07014

Novartis Investigative Site, Palma de Mallorca

SE-413 45

Novartis Investigative Site, Gothenburg

SE 171 76

Novartis Investigative Site, Stockholm

PL6 8DH

Novartis Investigative Site, Plymouth

TA1 5DA

Novartis Investigative Site, Taunton

L7 8XP

Novartis Investigative Site, Liverpool

E1 1BB

Novartis Investigative Site, London

NW1 2PG

Novartis Investigative Site, London

M13 9WL

Novartis Investigative Site, Manchester

RG1 5AN

Novartis Investigative Site, Reading

SA6 6NL

Novartis Investigative Site, Swansea